The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
Open accessAbstract
The mechanistic target of rapamycin complex 1 (mTORC1) controls cell growth and metabolism in response to nutrients, energy levels, and growth factors. It contains the atypical kinase mTOR and the RAPTOR subunit that binds to the Tor signalling sequence (TOS) motif of substrates and regulators. mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain) and inhibited by PRAS40. Here we present the 3.0 ångström cryo-electron microscopy structure of mTORC1 and the 3.4 ångström structure of activated RHEB-mTORC1. RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis. Cancer-associated hyperactivating mutations map to structural elements that maintain the inactive state, and we provide biochemical evidence that they mimic RHEB relieving auto-inhibition. We also present crystal structures of RAPTOR-TOS motif complexes that define the determinants of TOS recognition, of an mTOR FKBP12-rapamycin-binding (FRB) domain-substrate complex that establishes a second substrate-recruitment mechanism, and of a truncated mTOR-PRAS40 complex that reveals PRAS40 inhibits both substrate-recruitment sites. These findings help explain how mTORC1 selects its substrates, how its kinase activity is controlled, and how it is activated by cancer-associated mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High resolution structures of mTORC1 have provided a previously unprecedented look at how mTORC1 is activated by nutrients and how it is inhibited by rapamycin 155–157.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cryo-electron microscopy has revealed that Rheb-GTP binds allosterically to mTOR, resulting in a global conformational change that allosterically realigns the active-site residues to enable substrate phosphorylation 157.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [157]
In the citing paper
“Cross-linking of mTORC1 in the presence of RhebGTPgS and 4EBP1, another well-known mTORC1 substrate (Burnett et al., 1998), yielded the cryo-EM structure of mTORC1 bound to Rheb (Yang et al., 2017).”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Yang et al., 2017
In the citing paper
“Density corresponding to Rheb was observed at the N-terminal portions of the N- HEAT, M-HEAT and FAT domains, thereby resulting in a four-way interface where Rheb switch I residues bound the M-HEAT solenoid and FAT domain, and switch II formed contacts with all three mTORC1 domains.”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Yang et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Electrostatics of nanosystems: Application to microtubules and the ribosome
Baker, N., Sept, D., Joseph, S., Holst, M., & McCammon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181342398 · Cited by 7,125
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Cited by
Sorted by citations
Items 301–400 of 549
Doxsey, D. D., Tettoni, S. D., Egri, S. B., & Shen, K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104880 · Cited by 11
Structural Basis of Autophagy Regulatory Proteins
Pan, L., Liu, J., & Li, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0602-4_15 · Cited by 9
Role of mTOR Signaling Cascade in Epidermal Morphogenesis and Skin Barrier Formation
Wang, J., Eming, S. A., & Ding, X. (2022) · Biology · doi:10.3390/biology11060931 · Cited by 8
Morozumi, Y., Mahayot, F., Nakase, Y., Soong, J. X., Yamawaki, S., Sofyantoro, F., Imabata, Y., Oda, A., Tamura, M., Kofuji, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108777 · Cited by 8
Nalla, S., Pavani, Y., kumar, G. R., Sumalatha, P., Syed, T., & Subbarao, M. (2023) · Synthetic Communications · doi:10.1080/00397911.2023.2286473 · Cited by 8
Ragopathies and the rising influence of RagGTPases on human diseases
Sambri, I., Ferniani, M., & Ballabio, A. (2024) · Nature Communications · doi:10.1038/s41467-024-50034-4 · Cited by 8
Adhesive lipophilic gels delivering rapamycin prevent oral leukoplakia from malignant transformation
Du, Y., Liu, T., Ding, T., Zeng, X. Y., Chen, Q., & Zhao, H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101305 · Cited by 8
Tang, S., & Borlak, J. T. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70218 · Cited by 8
TNFAIP8L2 maintains hair cell function and regulates age-related hearing loss via mTORC1 signaling
Li, W., Li, Y., Wang, M., Liu, H., Hong, G., Jiang, L., Liu, Z., Wu, Y., Yuan, L., Zhao, X., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.046 · Cited by 8
Evolution of growth factor signaling to the TSC complex to regulate mTORC1
Wang, K., Lockwood, S. E., & Manning, B. D. (2025) · Science Signaling · doi:10.1126/scisignal.adw4165 · Cited by 8
Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation
Deaver, J. W., López, S. M., Ryan, P. J., Nghiem, P. P., Riechman, S. E., & Fluckey, J. D. (2020) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2020.11.003 · Cited by 8
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2020) · Genetics · doi:10.1093/genetics/iyaa010 · Cited by 9
Yang, A. J. T., Ahmad, M. A., Tsiani, E., Necakov, A., & MacPherson, R. E. K. (2022) · Cells · doi:10.3390/cells11152354 · Cited by 8
Self-citationAssembly of mTORC3 Involves Binding of ETV7 to Two Separate Sequences in the mTOR Kinase Domain
Zhan, J., Harwood, F. C., ten Have, S., Lamond, A. I., Phillips, A. H., Kriwacki, R. W., Halder, P., Cardone, M., & Grosveld, G. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810042 · Cited by 8
Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
Shams, R. S., Ito, Y., & Miyatake, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168766 · Cited by 8
Al‐Huseini, I., Sirasanagandla, S. R., Babu, K. S., Sofin, R. G. S., & Das, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220117114306 · Cited by 8
Alleviation of doxorubicin-induced cardiomyocyte death through miR-147-y-mediated mitophagy
Gao, H., Xian, G., Zhong, G., Huang, B., Liang, S., Zeng, Q., & Liu, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.013 · Cited by 8
Fallone, L., Pouxvielh, K., Arbez, L., Rousseaux, N., Picq, L., Drouillard, A., Mathieu, A., Nombel, A., Benezech, S., Bourdonnay, E., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adq8778 · Cited by 8
Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB
Chu, N. K., Le, N. T. T., Nebie, O., & Yang, S. (2026) · Biochemical Journal · doi:10.1042/bcj20253108 · Cited by 8
APEX2-Mediated Proximity Labeling Resolves the DDIT4-Interacting Proteome
Naki, M., Gourdomichali, O., Zonke, K., Kattan, F.-G., Makridakis, M., Kontostathi, G., Vlahou, A., & Doxakis, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095189 · Cited by 7
Development of an RHEB-Targeting Peptide To Inhibit mTORC1 Kinase Activity
Shams, R. S., Ito, Y., & Miyatake, H. (2022) · ACS Omega · doi:10.1021/acsomega.2c01865 · Cited by 8
Stary, D., Nepovimová, E., Kuča, K., & Bajda, M. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14126 · Cited by 8
Wang, Y., Liao, Y., Sun, Y., Mitra, B., Guo, R., Piedras, B. I., White, S., Tang, H.-Y., Asara, J. M., Tempera, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65760-6 · Cited by 7
Mislocalization of TORC1 to Lysosomes Caused by KIF11 Inhibition Leads to Aberrant TORC1 Activity.
Jang, Y., Choi, Y., Jun, K., & Chung, J. (2020) · PubMed Central · doi:10.14348/molcells.2020.0089 · Cited by 6
Pfeffer, B. A., Xu, L., & Fliesler, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052339 · Cited by 7
Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer
Zhu, Q., Qiao, R., Di, F., Song, Y., Zhang, J., Tian, X., Wang, Y., Dai, L., Gu, W., Han, B., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.10.014 · Cited by 7
Role of FLCN Phosphorylation in Insulin‐Mediated mTORC1 Activation and Tumorigenesis
Wang, G., Chen, L., Lei, X., Qin, S., Geng, H., Zheng, Y., Xia, C., Yao, J., Meng, T., & Deng, L. (2023) · Advanced Science · doi:10.1002/advs.202206826 · Cited by 7
Unmasking the True Identity of Rapamycin’s Minor Conformer
Crull, E. B., Jain, A. N., Hawkins, P. C. D., Cleves, A. E., Graziani, E. I., & Williamson, R. T. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00421 · Cited by 7
The 3.2Å resolution structure of human mTORC2Preprint
Scaiola, A., Mangia, F., Imseng, S., Boehringer, D., Berneiser, K., Shimobayashi, M., Stuttfeld, E., Hall, M. N., Ban, N., & Maier, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.10.029835 · Cited by 8
Lin, Y., Wu, Y., Liu, Y.-J., Yeh, W.-C., Huang, Y., Zhang, S.-A., Chen, A., Zheng, M., Liu, H.-M., Chou, F., et al. (2025) · Oncogenesis · doi:10.1038/s41389-025-00568-z · Cited by 6
PSAT1 inhibits MTORC1 activation by preventing RRAG heterodimer formation in lung adenocarcinoma
Liu, Y., Cheng, Z., Zhang, J., Zhang, Y., Zhao, T., Sun, L., Wen, G., Han, T., & Wang, J. (2025) · Autophagy · doi:10.1080/15548627.2025.2535765 · Cited by 6
Wang, Y., Sun, Y., Wang, C.-Y., Cao, M., Hao, R., Wang, S., & Sun, H.-J. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01702-8 · Cited by 6
EGO complex at 20: The Rag GTPase-TORC1 nutrient-sensing blueprint
VIRGILIO, C. D. (2026) · Molecular Cell · doi:10.1016/j.molcel.2025.12.018 · Cited by 6
Coordinated Regulation of Myelination by Growth Factor and Amino-acid Signaling Pathways
Yang, Z., Yu, Z., & Xiao, B. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00967-x · Cited by 6
Bagh, M. B., Appu, A. P., Sadhukhan, T., Mondal, A., Plavelil, N., Raghavankutty, M., Supran, A. M., Sadhukhan, S., Liu, A., & Mukherjee, A. B. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105641 · Cited by 7
A strategy for improving silk yield and organ size in silk‐producing insects
Tang, X., Liu, H., Chang, L., Wang, X., Liu, Q., Tang, Z., Xia, Q., & Zhao, P. (2024) · FEBS Journal · doi:10.1111/febs.17193 · Cited by 6
Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study
Ducatez, F., Berger, M. G., Pilon, C., Plichet, T., Lesueur, C., Berger, J., Belmatoug, N., Marret, S., Bekri, S., & Tebani, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02512-x · Cited by 6
Xu, W., Fang, H., Cao, X., Xu, M.-Z., Yan, Y., Shen, M., Yang, Y., & Jiang, K. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07638-5 · Cited by 6
Structural insights into cholesterol sensing by the LYCHOS-mTORC1 pathway
Yu, S., Ding, J.-H., Wang, J.-L., Wang, W.-Z., Zuo, P., Yang, A., Dai, Z.-L., Yin, Y.-X., Sun, J.-P., & Liang, L. (2025) · Nature Communications · doi:10.1038/s41467-025-61966-w · Cited by 6
Self-citationRegulation of TORC2 function and localization by Rab5 GTPases inSaccharomyces cerevisiae
Locke, M. N., & Thorner, J. W. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1616999 · Cited by 8
Dichloroacetic acid and rapamycin synergistically inhibit tumor progression
Chen, H., Liang, K., Hou, C., & Piao, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200356 · Cited by 6
How mTORC1 makes sense of nutrients
Luciani, A., & Stagi, M. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.052 · Cited by 6
mTOR–mLST8 interaction: hot spot identification through quantum biochemistry calculations
de Oliveira, F. L. S., Carletti, J. V., Azevedo, F. F. N., de Sousa, F. J. F., Caetano, E. W. S., Freire, V. N., & Zanatta, G. (2020) · New Journal of Chemistry · doi:10.1039/d0nj04099a · Cited by 6
Zhao, Y., Guo, H., Wang, W., Zheng, G., Wang, Z., Wang, X., & Zhang, Y. (2021) · Human Genomics · doi:10.1186/s40246-021-00344-1 · Cited by 6
Tsverov, J., Yegorov, K., & Powers, T. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-12-0611 · Cited by 6
AMPK: an enzyme that may be effective in cancer and metabolic diseases
Güney-Kalkan, S., & Ceylan‐Ünlüsoy, M. (2025) · Discover Oncology · doi:10.1007/s12672-025-02229-4 · Cited by 5
CASTOR1 and CASTOR2 respond to different arginine levels to regulate mTORC1 activity.
Liu, C., Zhang, Y., Wang, Y., Wu, M., Li, Y.-C., Wei, J., Shi, J., Wang, R., Su, L., Yang, T., et al. (2026) · Molecules and Cells · doi:10.1016/j.molcel.2025.12.016 · Cited by 6
Kamada, Y., Umeda, C., Mukai, Y., Ohtsuka, H., Otsubo, Y., Yamashita, A., & Kosugi, T. (2024) · Journal of Cell Science · doi:10.1242/jcs.261625 · Cited by 5
mTORC1 pathway activity biases cell fate choice
Wang, Y., Papayova, M., Warren, E., & Pears, C. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-71298-2 · Cited by 6
Making PI3K superfamily enzymes run faster
Gong, G. Q., Anandapadamanaban, M., Islam, M. S., Hay, I. M., Bourguet, M., Špokaitė, S., Dessus, A. N., Ohashi, Y., Perišić, O., & Williams, R. L. (2024) · Advances in Biological Regulation · doi:10.1016/j.jbior.2024.101060 · Cited by 5
Alizadeh, H., Kerachian, S., Jabbari, K., & Soltani, B. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177220 · Cited by 5
Du, F., Lu, Z., Wu, Q., Zhang, X., Zheng, X.-L., Zhang, R., & Wang, Q. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01064 · Cited by 5
Nikolic, M. R., Novakovic, J. N., Ramenskaya, G. V., Kokorekin, V. A., Jeremic, N. S., & Jakovljevic, V. L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00944-4 · Cited by 5
Lamming, D. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823679-6.00002-3 · Cited by 4
Arf5-mediated regulation of mTORC1 at the plasma membrane
Makhoul, C., Houghton, F. J., Hinde, E., & Gleeson, P. A. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-07-0302 · Cited by 5
Protein interaction network analysis of mTOR signaling reveals modular organization
Wehle, D. T., Bass, C. S., Šulc, J., Mirzaa, G., & Smith, S. E. P. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105271 · Cited by 5
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 5
Miller, M. J., Akter, D., Mahmud, J., & Chan, G. C. T. (2024) · Journal of Virology · doi:10.1128/jvi.01888-23 · Cited by 5
Self-citationBioinformatic insights into sugar signaling pathways in sugarcane growth
de Oliveira, L. P., Pereira, J. P. D. J., Navarro, B. V., Martins, M. C. M., Riaño‐Pachón, D. M., & Buckeridge, M. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-75220-8 · Cited by 5
Layoun, A., Goldberg, A. A., Baig, A., Eng, M., Attias, O., Nelson, K., Carella, A., Amberber, N., Fielhaber, J. A., Joung, K.-B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53909-5 · Cited by 5
The activation mechanisms of master kinases in the DNA damage response
Xiao, J., Rao, Q., & Xu, Y. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00045-y · Cited by 5
Porcine Hemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independently of ULK1
Li, Z., Gao, F., Lan, Y., Guan, J., Zhang, J., Lu, H., Zhao, K., & He, W. (2021) · Journal of Virology · doi:10.1128/jvi.00851-21 · Cited by 5
Amino Acid Sensing: Architecture of mTORC1 on the Lysosome Surface
Peng, W., & Jewell, J. L. (2020) · Current Biology · doi:10.1016/j.cub.2019.11.087 · Cited by 5
Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases
Kim, S., Lee, S. Y., Jung, U. J., & Kim, S. R. (2025) · Experimental Neurobiology · doi:10.5607/en25023 · Cited by 5
Asymmetric activation of dimeric ATM/Tel1 kinase
Wang, P., Zheng, Z., Wang, G., Zhao, Z., Qian, D., Cai, G., & Wang, X. (2025) · Cell Discovery · doi:10.1038/s41421-025-00786-0 · Cited by 4
O’Leary, K. M., Ślężak, T., & Kossiakoff, A. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424679122 · Cited by 5
Xie, X., Yan, J., Zhang, J., Ye, H., Li, J., & Yin, W. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118707 · Cited by 4
Tai, Y.-T., Fukuda, T., Morozumi, Y., Hirai, H., Oda, A. H., Kamada, Y., Akikusa, Y., Kanki, T., Ohta, K., & Shiozaki, K. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2282349 · Cited by 5
The molecular logic of Gtr1/2- and Pib2-dependent TORC1 regulation in budding yeast
Cecil, J. H., Padilla, C. M., Lipinski, A. A., Langlais, P. R., Luo, X., & Capaldi, A. P. (2025) · eLife · doi:10.7554/elife.94628.2 · Cited by 4
OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN
Li, J., Yang, D., Lin, Y., Xu, W., Zhao, S.-M., & Wang, C.-J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1337732 · Cited by 5
Yang, L., Liao, J., Huang, H., Lee, T., & Qi, H. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.02.002 · Cited by 4
Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTOR
Rameh, L. E., York, J. D., & Blind, R. D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108095 · Cited by 5
Calmodulin enhances mTORC1 signaling by preventing TSC2-Rheb binding
Amemiya, Y., Ioi, Y., Araki, M., Kontani, K., Maki, M., Shibata, H., & Takahara, T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108122 · Cited by 4
Non-dikarya fungi share the TORC1 pathway with animals, not with Saccharomyces cerevisiae
Barua, D., Płecha, M., & Muszewska, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89635-4 · Cited by 5
Ren, S., Zhu, J., Shan, G., Liang, J., Bian, Y., Lin, H., Shi, H., Pan, B., Zhao, G., Yang, H., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03278-7 · Cited by 4
Self-citationZhang, C., Liu, Y., Zhang, Y., Wang, X., Zhang, T., & Ding, J. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa025 · Cited by 4
Une moisson de nouvelles structures de mTORC1
Nawrotek, A., & Cherfils, J. (2021) · médecine/sciences · doi:10.1051/medsci/2021033 · Cited by 4
Rheb Promotes Triglyceride Secretion and Ameliorates Diet-Induced Steatosis in the Liver
Du, C., Yang, W., Yu, Z., Yuan, Q., Pang, D., Tang, P., Jiang, W., Chen, M., & Xiao, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.808140 · Cited by 4
Chen, W., Chen, J., Cheng, Z., Chen, W., & Zhang, H. (2025) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2024.2446840 · Cited by 3
Li, Z., Guan, Y., Gao, J., Zhu, L., Zeng, Z., Jing, Q., Wan, Q., Fan, Q., Ren, X., Pei, H., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03320-4 · Cited by 3
Shin, J., Tighanimine, K., Cormerais, Y., Rosenthal, D. M., Niroula, P., Lapp, S. C., Kalafut, K. C., Cissé, M. Y., Schrötter, S., & Manning, B. D. (2025) · iScience · doi:10.1016/j.isci.2025.114204 · Cited by 3
Xing, H., Ma, F., Li, P., Xuan, M., Liu, Y., Fu, L., Lou, N., Liu, Y., Zhang, S., Xu, Z., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03806-9 · Cited by 4
Structures of Mec1/ATR kinase endogenously stimulated by different genotoxins
Zhang, Q.-J., Wang, P., Wu, T., Zhang, Y., Zheng, Z., Zhou, S., Qian, D., Wang, X., & Cai, G. (2022) · Cell Discovery · doi:10.1038/s41421-022-00461-8 · Cited by 3
Rheb1 is required for limb growth through regulating chondrogenesis in growth plate
Zhang, Y., Wen, J., Lai, R., Zhang, J., Li, K., Zhang, Y., Liu, A., & Bai, X. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03861-2 · Cited by 3
Yao, Y., Hong, S., Yoshida, S., Swaroop, V., Curtin, B., & Inoki, K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115101 · Cited by 3
Exosomes derived from cancer-associated fibrolasts mediated ciplatin resistance
Meng, Y., Shao, H., & Wu, L. (2024) · CytoJournal · doi:10.25259/cytojournal_149_2024 · Cited by 3
Yang, Y., Song, W.-J., & Zhang, J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i6.104973 · Cited by 3
The Rab18/Ras/ERK/FosB/MMP3 Signaling Pathway Mediates Cell Migration Regulation by 2′3′-cGAMP
Deng, Y., Yuan, R., & Liu, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125758 · Cited by 3
Structural basis for TORC2 activation
Zou, L., Tettamanti, M. G., Gabus, C., Bergmann, A., Loewith, R., & Tafur, L. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.03.022 · Cited by 3
Structure and mechanism of the RalGAP tumor suppressor complex
Rasche, R., Klink, B. U., Apken, L. H., Michalke, E., Chen, M., Oeckinghaus, A., Gatsogiannis, C., & Kümmel, D. (2025) · Nature Communications · doi:10.1038/s41467-025-61743-9 · Cited by 3
Insights into DEPTOR regulation from in silico analysis of DEPTOR complexes
Teh, A.-H., Yeap, K.-H., & Hisano, T. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107602 · Cited by 4
Lee, W. S., Macdonald‐Laurs, E., Stephenson, S. E. M., D’Arcy, C. E., MacGregor, D. P., Leventer, R. J., Maixner, W. J., Harvey, A. S., & Lockhart, P. J. (2022) · Epilepsia Open · doi:10.1002/epi4.12678 · Cited by 3
Myburgh, E., Geoghegan, V., Alves‐Ferreira, E. V. C., Nievas, Y. R., Grewal, J. S., Brown, E. H., McLuskey, K., & Mottram, J. C. (2024) · EMBO Reports · doi:10.1038/s44319-024-00084-y · Cited by 3
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis
Pacyna, C. N., Anandapadamanaban, M., Loudon, K. W., Hay, I. M., Perišić, O., Li, R., Byrne, M., Allen, L., Roberts, K., Hooks, Y. E., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03137-7 · Cited by 3
Cicala, C. M., Matito, J., Quindós, M., Gómez-Peregrina, D., Romero-Lozano, P., Fernández-Suárez, P., Valverde, C. M., González, M., Landolfi, S., Pérez‐Albert, P., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00497 · Cited by 3
Tettoni, S. D., Egri, S. B., Doxsey, D. D., Veinotte, K., Ouch, C., Chang, J.-Y., Song, K., Chen, X., & Shen, K. (2023) · Structure · doi:10.1016/j.str.2023.06.012 · Cited by 3
Dai, D. L., Hasan, S. M. N., Woollard, G., Abbas, Y. M., Bueler, S. A., Julien, J., Rubinstein, J. L., & Mazhab‐Jafari, M. T. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00269 · Cited by 3
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/606699 · Cited by 3
Cui, Z., Esposito, A., Napolitano, G., Ballabio, A., & Hurley, J. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.15.623810 · Cited by 3
Zhao, Z., Liu, J., Gao, X., Chen, Z., Hu, Y., Chen, J., Zang, W., & Xue, W. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05938-5 · Cited by 2
Metadata
- Authors
- Yang, H., Jiang, X., Li, B., Yang, H. J., Miller, M., Yang, A., Dhar, A., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 368-373
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5750076
- OpenAlex
- W2773300145
- Cited by
- 548
- References
- 55
- Citations by year
- 2026: 55 · 2025: 65 · 2024: 68 · 2023: 66 · 2022: 63 · 2021: 80 · 2020: 74 · 2019: 53 · 2018: 23
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Memorial Sloan-Kettering Cancer Center (CA008748)
- National Institutes of Health (CA008748)
- National Cancer Institute (P30CA008748)
- National Institute of General Medical Sciences (P41GM103310, R01GM064644)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTORC1, Rheb, PRAS40, allosteric activation, allosteric inhibition, raptors, substrate recognition, cancer-associated mutations, mTOR hyperactivation, protein complex structure, cell growth regulation
- MeSH terms
- Protein Domains, Ras Homolog Enriched in Brain Protein, Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Binding Sites, Enzyme Activation, Humans, Models, Molecular, Mutation, Neoplasms, Protein Binding, Substrate Specificity, Signal Transduction, Crystallography, X-Ray, Sirolimus, Catalytic Domain, Cryoelectron Microscopy, Amino Acid Motifs, Tacrolimus Binding Protein 1A, Ribosomal Protein S6 Kinases, 70-kDa, Adaptor Proteins, Signal Transducing, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review